Cornerstone National Bank & Trust’s AbbVie ABBV Stock Holding History

Cornerstone National Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$414K	Buy	1,650 +1,000	+154%	+$215K	0.14%	69
2026 Q1	$140K	Hold	650	–	–	0.05%	86
2025 Q4	$149K	Hold	650	–	–	0.06%	71
2025 Q3	$151K	Hold	650	–	–	0.06%	68
2025 Q2	$121K	Hold	650	–	–	0.05%	72
2025 Q1	$136K	Hold	650	–	–	0.06%	67
2024 Q4	$116K	Hold	650	–	–	0.05%	70
2024 Q3	$128K	Buy	+650	New	+$121K	0.06%	68

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Cornerstone National Bank & Trust's ABBV Position: Q2 2026 in Review

Cornerstone National Bank & Trust increased its AbbVie (ABBV) stake by 154% in Q2 2026, buying an estimated $215K and bringing the position to 1,650 shares worth $414K. The position accounts for 0.14% of the portfolio, ranked #69.

Cornerstone National Bank & Trust first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cornerstone National Bank & Trust held 1,650 shares of AbbVie worth $414K as of Q2 2026.
Cornerstone National Bank & Trust bought 1,000 AbbVie shares in Q2 2026, an estimated $215K.
AbbVie made up 0.14% of Cornerstone National Bank & Trust's portfolio in Q2 2026, its #69 holding.
Cornerstone National Bank & Trust first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.